These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
608 related items for PubMed ID: 29084336
1. Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia. Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Hicks LA, Bramley AM, Jain S, Grijalva CG. JAMA Pediatr; 2017 Dec 01; 171(12):1184-1191. PubMed ID: 29084336 [Abstract] [Full Text] [Related]
5. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia. Gilbert TT, Arfstrom RJ, Mihalovic SW, Dababneh AS, Varatharaj Palraj BR, Dierkhising RA, Mara KC, Lessard SR. Am J Ther; 2020 May 01; 27(2):e177-e182. PubMed ID: 30418221 [Abstract] [Full Text] [Related]
6. Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study. Ito A, Ishida T, Tachibana H, Nakanishi Y, Tokioka F, Yamazaki A, Washio Y, Irie H, Otake T. J Infect Chemother; 2021 Oct 01; 27(10):1447-1453. PubMed ID: 34147355 [Abstract] [Full Text] [Related]
10. Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials. Choi SH, Cesar A, Snow TAC, Saleem N, Arulkumaran N, Singer M. Int J Antimicrob Agents; 2023 Sep 01; 62(3):106905. PubMed ID: 37385561 [Abstract] [Full Text] [Related]
13. Comparative Effectiveness of Beta-lactam Versus Macrolide Monotherapy in Children with Pneumonia Diagnosed in the Outpatient Setting. Ambroggio L, Test M, Metlay JP, Graf TR, Blosky MA, Macaluso M, Shah SS. Pediatr Infect Dis J; 2015 Aug 01; 34(8):839-42. PubMed ID: 25955834 [Abstract] [Full Text] [Related]
15. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis. Raz-Pasteur A, Shasha D, Paul M. Int J Antimicrob Agents; 2015 Sep 01; 46(3):242-8. PubMed ID: 26092096 [Abstract] [Full Text] [Related]
16. Impact of guideline-concordant antibiotics and macrolide/β-lactam combinations in 3203 patients hospitalized with pneumonia: prospective cohort study. Asadi L, Eurich DT, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Majumdar SR. Clin Microbiol Infect; 2013 Mar 01; 19(3):257-64. PubMed ID: 22404691 [Abstract] [Full Text] [Related]
18. The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization. Peyrani P, Wiemken TL, Metersky ML, Arnold FW, Mattingly WA, Feldman C, Cavallazzi R, Fernandez-Botran R, Bordon J, Ramirez JA. Infect Dis (Lond); 2018 Jan 01; 50(1):13-20. PubMed ID: 28699429 [Abstract] [Full Text] [Related]
19. [Comparison of the combination and quinolone therapy in community acquired pneumonia]. Kılıç Soylar Ö, Kılınç O, Ellidokuz H. Tuberk Toraks; 2015 Sep 01; 63(3):165-9. PubMed ID: 26523897 [Abstract] [Full Text] [Related]